Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
27.75
+0.01 (0.04%)
At close: Dec 5, 2025, 4:00 PM EST
28.30
+0.55 (1.98%)
After-hours: Dec 5, 2025, 7:47 PM EST
Upstream Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Upstream Bio stock have an average target of 43.5, with a low estimate of 40 and a high estimate of 47. The average target predicts an increase of 56.76% from the current stock price of 27.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Upstream Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +44.14% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +69.37% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +36.94% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 5, 2024 |
Financial Forecast
Revenue This Year
2.79M
from 2.37M
Increased by 17.51%
Revenue Next Year
1.44M
from 2.79M
Decreased by -48.22%
EPS This Year
-2.63
from -5.58
EPS Next Year
-3.05
from -2.63
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.2M | 3.0M | ||||
| Avg | 2.8M | 1.4M | ||||
| Low | 2.1M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 32.9% | 9.3% | ||||
| Avg | 17.5% | -48.2% | ||||
| Low | -9.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.65 | -2.71 | ||||
| Avg | -2.63 | -3.05 | ||||
| Low | -2.72 | -3.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.